← Back to all earnings calls

Serina Therapeutics, Inc. Q2 FY2022 Earnings Call

Serina Therapeutics, Inc. (SER)

Earnings Call FY2022 Q2 Call date: 2022-08-12 Concluded

Share

Quarter scorecard

Revenue

$12,000

-67.6% YoY

Diluted EPS

$-2.50

Gross margin

50.0%

-14.9 pp YoY

Net income

$

Documents & deck